The new Professorship reflects the University and department’s strategic commitment to strengthening its research in therapeutic and regulatory health data science. It will support the generation of evidence to improve regulatory decision making, while strengthening the monitoring of medicines, vaccines and medical devices.
In this inaugural role Professor Daniel Prieto-Alhambra will expand collaborations across the University of Oxford, the UK and with regulators and industry nationally and internationally to facilitate multidisciplinary research to bring effective and safe treatments and devices to benefit human health.
Daniel is internationally recognised for his work in pharmaco-epidemiology and the use of routinely collected health data to improve patient care and inform regulatory decisions. His research has helped shape the safe and effective use of medicines through close collaboration with regulators, healthcare systems and industry partners internationally.
Commenting on the appointment, Daniel said: 'This Chair is a recognition of my team's achievements and the University of Oxford’s innovative vision on the use of real-world data. This Professorship in Regulatory Health Data Science will make it possible for myself and the team to deliver methods and data for better regulatory decision making. I will work to bring people with me to make my vision for this Chair a reality, which includes the setting up of infrastructures and networks for better data, research, training, and outreach in Regulatory Science nationally and internationally.'
Professor Jonathan Rees, NDORMS Head of Department said: ‘We created this Professorship to support our plans for a new therapeutics and regulatory innovation centre in NDORMS and our aspirations for Oxford to lead nationally and internationally in this field. We will be working with multiple stakeholders including industry partners and regulatory authorities to develop new efficient regulatory frameworks to advance safe drug and device development for human benefit. Regulatory health data science will play a major part in this enterprise and Daniel has been instrumental in developing the methods and international partnerships to make this new venture a global success.'
Starting the Professorship on 1 August 2026, Daniel will also hold a Fellowship at St Hilda’s College. ‘My new role as Professorial Fellow at Saint Hilda’s is an extremely exciting opportunity, and I cannot wait to meet the college faculty and to see how I can contribute to such an excellent community,’ he said.